Evidence map›Paper›PMID 25380286›Full record

ArticlePloS one2014

25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation.

Nan Lan, Guangyan Luo, Xiaoqiong Yang, Yuanyuan Cheng, Yun Zhang, Xiaoyun Wang, Xing Wang, Tao Xie, Guoping Li, Zhigang Liu and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Vitamin D for the management of asthma.The Cochrane database of systematic reviews · 2023
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Role of Vitamins in the Pathogenesis of Asthma.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Nan LanInflammations & Allergic Diseases Research Unit, Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, China.
Guangyan LuoHygiene Section, Luzhou Medical College, Luzhou, 646000, Sichuan, China.
Xiaoqiong YangInflammations & Allergic Diseases Research Unit, Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, China.
Yuanyuan ChengInflammations & Allergic Diseases Research Unit, Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, China.
Yun ZhangInflammations & Allergic Diseases Research Unit, Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, China.
Xiaoyun WangInflammations & Allergic Diseases Research Unit, Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, China.
Xing WangInflammations & Allergic Diseases Research Unit, Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, China.
Tao XieInflammations & Allergic Diseases Research Unit, Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, China.
Guoping LiInflammations & Allergic Diseases Research Unit, Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, China; State Key Laboratory of Respiratory Disease for Allergy at Shengzhen University, School of Medicine, Shenzhen University, Nanhai Ave 3688, Shenzhen, Guangdong, 518060, PR China.
Zhigang LiuState Key Laboratory of Respiratory Disease for Allergy at Shengzhen University, School of Medicine, Shenzhen University, Nanhai Ave 3688, Shenzhen, Guangdong, 518060, PR China.
Nanshan ZhongState Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangdong, 510120, PR China.
Southwest Medical University · CNFirst Affiliated Hospital of Sichuan Medical University · CNGuangzhou Medical University · CNShenzhen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress plays a significant role in exacerbation of asthma. The role of vitamin D in oxidative stress and asthma exacerbation remains unclear. We aimed to determine the relationship between vitamin D status and oxidative stress in asthma exacerbation. Severe asthma exacerbation patients with 25-hydroxyvitamin D3-deficiency (V-D deficiency) or 25-hydroxyvitamin D-sufficiency (V-D sufficiency) were enrolled. Severe asthma exacerbation with V-D-deficiency showed lower forced expiratory volume in one second (FEV1) compared to that with V-D-sufficiency. V-D-deficiency intensified ROS release and DNA damage and increased TNF-α, OGG1 and NFκB expression and NFκB phosphorylation in severe asthma exacerbation. Supplemental vitamin D3 significantly increased the rates of FEV1 change and decreased ROS and DNA damage in V-D-deficiency. Vitamin D3 inhibited LPS-induced ROS and DNA damage and were associated with a decline in TNF-α and NFκB in epithelial cells. H2O2 reduces nuclear translocation of glucocorticoid receptors in airway epithelial cell lines. V-D pretreatment enhanced the dexamethasone-induced nuclear translocation of glucocorticoid receptors in airway epithelial cell lines and monocytes from 25-hydroxyvitamin D3-deficiency asthma patients. These findings indicate that V-D deficiency aggravates oxidative stress and DNA damage, suggesting a possible mechanism for corticosteroid resistance in severe asthma exacerbation.

Indexed as

Drug ResistanceActive Transport, Cell NucleusAdrenal Cortex HormonesAsthmaCalcifediolCell LineCell NucleusDexamethasoneDNA DamageEpithelial CellsFemaleForced Expiratory VolumeHumansLipopolysaccharidesMaleMiddle AgedAdrenal Cortex HormonesCalcifediolDexamethasoneLipopolysaccharidesNF-kappa BReceptors, GlucocorticoidSuperoxide DismutaseTumor Necrosis Factor-alpha

Identifiers

PMID25380286
PMCPMC4224414
OpenAlexW1964152652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.